Catherine Ley
Plus aucun poste en cours
Profil
Catherine Ley is Director of Virtual Biotech Services for CollabRx, Inc. Previously, she was Principal at Caradon Consulting and Senior Scientist and Epidemiologist at the Institute for OneWorld Health.
Ms. Ley received an MS degree and BS degree in Biological Sciences from Stanford University as well as PhD in Epidemiology from the University of California, Berkeley.
Anciens postes connus de Catherine Ley
| Sociétés | Poste | Fin |
|---|---|---|
CollabRx, Inc. /Old/
 CollabRx, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services CollabRx uses information technology to inform personalized cancer treatment planning by combining the world's knowledge on cutting-edge therapies with specific insights from the nation's top cancer experts starting with the area of greatest need advanced cancers in patients who have effectively exhausted the standard of care. For physicians, Collabrx provides sophisticated, yet intuitive decision support tools to help them rapidly and accurately determine which medical tests, therapies, and clinical trials should be considered in order to deliver the best possible care to their patients. For patients, CollabRx provides actionable and highly-credible information that can be shared with their oncologist in a form that supports collaborative decision making in determining a cancer treatment plan that is customized for them. For researchers, CollabRx provides a framework to categorize the molecular subtypes of cancer based on the genetic profile of the tumor, and more importantly link specific subtypes to relevant treatments and ultimately patient clinical outcomes to drive the science and medicine forward. | Corporate Officer/Principal | 27/09/2012 |
| PATH Drug Solutions | Corporate Officer/Principal | - |
Formation de Catherine Ley
| University of California, Berkeley | Doctorate Degree |
| Stanford University | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
CollabRx, Inc. /Old/
CollabRx, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services CollabRx uses information technology to inform personalized cancer treatment planning by combining the world's knowledge on cutting-edge therapies with specific insights from the nation's top cancer experts starting with the area of greatest need advanced cancers in patients who have effectively exhausted the standard of care. For physicians, Collabrx provides sophisticated, yet intuitive decision support tools to help them rapidly and accurately determine which medical tests, therapies, and clinical trials should be considered in order to deliver the best possible care to their patients. For patients, CollabRx provides actionable and highly-credible information that can be shared with their oncologist in a form that supports collaborative decision making in determining a cancer treatment plan that is customized for them. For researchers, CollabRx provides a framework to categorize the molecular subtypes of cancer based on the genetic profile of the tumor, and more importantly link specific subtypes to relevant treatments and ultimately patient clinical outcomes to drive the science and medicine forward. | Commercial Services |
| PATH Drug Solutions | Commercial Services |
